Zacytuj

Fig. 1

Timeline for clinical evaluation and blood sampling
Timeline for clinical evaluation and blood sampling

Fig 2

Amplification product of the variable region of 16s rRNA (783pz) of Dichelobacter nodosus from samples tested*K+ Dichelobacter nodosus ATCC25549
Amplification product of the variable region of 16s rRNA (783pz) of Dichelobacter nodosus from samples tested*K+ Dichelobacter nodosus ATCC25549

Antioxidant capacity, antioxidant/ oxidant balance, oxidative status

Measurement ABTS (μmolTe/mL) RP (μmolTe/mL) MDA (nmol/mL) AOB by ABTS (% of T0) AOB by RP (% of T0)
Control 1.22 ± 0.01 0.14 ± 0.02 6.2 ± 0.18
T0 1.16 ± 0.04 0.1 ± 0.02 7.84 ± 0.18
T1 1.23 ± 0.03* 0.14 ± 0.01* 6.45 ± 0.39 129.93 ± 19.1 169.2 ± 22.0
T2 1.2 ± 0.07 0.13 ± 0.01* 7.4 ± 0.2 110.00 ± 16.2 130.77 ± 17.0

Changes in plasma concentration of selected acute-phase proteins in the course of local ozone treatment in sheep (n = 10)

Protein Control Day 0 Day 7 Day 11
Fibrinogen (g/L) 4.10 ± 1.00 4.97 ± 0.51 4.67 ± 0.61* 5.06 ± 0.61*
Haptoglobin (g/L) 0.22 ± 0.20 0.61 ± 0.13 0.35 ± 0.11* 0.67 ± 0.16*
eISSN:
2450-8608
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Life Sciences, Molecular Biology, Microbiology and Virology, other, Medicine, Veterinary Medicine